Nerve Growth Factor Nanoparticles to Cross the Blood-Brain Barrier

神经生长因子纳米粒子跨越血脑屏障

基本信息

  • 批准号:
    8679894
  • 负责人:
  • 金额:
    $ 7.3万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-02-01 至 2016-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The blood-brain barrier (BBB) is the bottleneck in drug development for central nervous system (CNS) disorders. Only lipophilic molecules of less than 400 Da can cross the BBB. The lack of efficient delivery technologies prevents over 95% of molecules for CNS drug development. Receptor-mediated transport systems were used to deliver drugs across the BBB. Scavenger receptor class B type I (SR- BI) is highly expressed at the apical membrane of brain capillary endothelial cells, and facilitates selective uptake of high-density lipoprotein (HDL)-associated cholesteryl ester and a-tocopherol by receptor-mediated transcytosis. We previously developed the lipid-based nanoparticles that contain d-α-tocopheryl polyethylene glycol 1000 succinate (vitamin E TPGS), a water-soluble source of α- tocopherol, on the surface of the NPs. Nerve growth factor (NGF) is essential for the development and phenotype maintenance of neurons in the peripheral nervous system and for the functional integrity of cholinergic neurons in the CNS. NGF has great therapeutic potentials for various CNS disorders. We now propose to modify the nanoparticles and prepare HDL-mimicking α-tocopherol-coated NGF nanoparticles to target the brain. The novel nanoparticles will be prepared using the components of natural HDL and coated with vitamin E TPGS. NGF will be incorporated into the nanoparticles by an ion-pair strategy. The optimal NGF nanoparticles will be evaluated for the biological activity and the ability to cross the BBB by SR-BI-mediated transcytosis.
描述(由申请人提供):血脑屏障(BBB)是中枢神经系统(CNS)疾病药物开发的瓶颈。只有小于400 Da的亲脂性分子才能穿过BBB。缺乏有效的递送技术阻碍了超过95%的分子用于CNS药物开发。受体介导的转运系统用于递送药物穿过BBB。I型B类清道夫受体(SR-BI)在脑毛细血管内皮细胞的顶膜处高度表达,并通过受体介导的转胞吞作用促进高密度脂蛋白(HDL)相关胆固醇酯和α-生育酚的选择性摄取。我们先前开发了基于脂质的纳米颗粒,其在纳米颗粒表面上含有d-α-生育酚聚乙二醇1000琥珀酸酯(维生素E TPGS),这是α-生育酚的水溶性来源。神经生长因子(NGF)对于周围神经系统神经元的发育和表型维持以及中枢神经系统胆碱能神经元的功能完整性至关重要。神经生长因子对各种中枢神经系统疾病具有巨大的治疗潜力。我们现在建议修饰纳米颗粒并制备HDL模拟α-生育酚包覆的NGF纳米颗粒以靶向大脑。这种新型的纳米颗粒将使用天然HDL的组分制备,并用维生素E TPGS包覆。将通过离子对策略将NGF掺入纳米颗粒中。将评价最佳的NGF纳米颗粒的生物活性和通过SR-BI介导的转胞吞作用穿过BBB的能力。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Xiaowei Dong其他文献

Xiaowei Dong的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Xiaowei Dong', 18)}}的其他基金

HEMAVET 950FS Purchasing for NIGMS R35 Award
HEMAVET 950FS 为 NIGMS R35 奖采购
  • 批准号:
    10389016
  • 财政年份:
    2020
  • 资助金额:
    $ 7.3万
  • 项目类别:
Novel Formulation Technology to Enhance Oral Absorption of Water-insoluble Drugs
增强水不溶性药物口服吸收的新型制剂技术
  • 批准号:
    10205113
  • 财政年份:
    2020
  • 资助金额:
    $ 7.3万
  • 项目类别:
Novel Formulation Technology to Enhance Oral Absorption of Water-insoluble Drugs
增强水不溶性药物口服吸收的新型制剂技术
  • 批准号:
    10728429
  • 财政年份:
    2020
  • 资助金额:
    $ 7.3万
  • 项目类别:
Novel Formulation Technology to Enhance Oral Absorption of Water-insoluble Drugs
增强水不溶性药物口服吸收的新型制剂技术
  • 批准号:
    10792061
  • 财政年份:
    2020
  • 资助金额:
    $ 7.3万
  • 项目类别:
Research Supplements for R35 to Promote Diversity in Health-Related Research, PA-21-071
R35 研究补充剂促进健康相关研究的多样性,PA-21-071
  • 批准号:
    10612236
  • 财政年份:
    2020
  • 资助金额:
    $ 7.3万
  • 项目类别:
Novel Formulation Technology to Enhance Oral Absorption of Water-insoluble Drugs
增强水不溶性药物口服吸收的新型制剂技术
  • 批准号:
    10652554
  • 财政年份:
    2020
  • 资助金额:
    $ 7.3万
  • 项目类别:
Novel Formulation Technology to Enhance Oral Absorption of Water-insoluble Drugs
增强水不溶性药物口服吸收的新型制剂技术
  • 批准号:
    10029438
  • 财政年份:
    2020
  • 资助金额:
    $ 7.3万
  • 项目类别:
Novel Formulation Technology to Enhance Oral Absorption of Water-insoluble Drugs
增强水不溶性药物口服吸收的新型制剂技术
  • 批准号:
    10433965
  • 财政年份:
    2020
  • 资助金额:
    $ 7.3万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 7.3万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 7.3万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 7.3万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 7.3万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 7.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 7.3万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 7.3万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 7.3万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 7.3万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 7.3万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了